Cigna Group Delivers Q3 Beat as 2027 Outlook Takes Shape, RBC Says

MT Newswires Live
11/19

Cigna Group's (CI) Q3 beat was driven by solid performance in Cigna Healthcare and continued momentum in Specialty and Care Services, RBC Capital Markets said in a note Wednesday.

Following the results, management expressed confidence in achieving at least 10% adjusted earnings per share growth from an about $30 base, adjusted for its exit from the Affordable Care Act, or ACA, exchange market, the analysts said.

The analysts said they are raising their 2026 adjusted EPS estimate to $30.66 from $30.49. However, they lowered their 2027 adjusted EPS estimate to $33.04 from $33.53.

The analysts added that this reduction mainly reflects stranded overhead costs from Cigna's ACA market exit and softer Evernorth margins due to smaller rebate pools and lower employer coverage of GLP-1 weight-loss drugs.

RBC raised its price target on Cigna to $346 from $337 while keeping its outperform rating.

Price: 271.94, Change: -13.44, Percent Change: -4.71

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10